J Vadgama

Vice President for Research and Health Affairs. Professor of Medicine

Charles R. Drew University of Medicine and Science

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

J Vadgama is the Vice President for Research and Health Affairs and a Professor of Medicine at Charles R. Drew University of Medicine and Science. His research areas encompass cancer prevention and treatment, with recent articles focusing on the chemoprevention of prostate cancer, drug bioavailability, health equity, and the impact of inflammatory cytokines on breast cancer risk among underserved populations. Dr. Vadgama's work aims to advance understanding of cancer pathogenesis and explore innovative therapies in the context of chronic diseases.

Articles (17)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2020

Collaborators (3)

John Schloss

Associate Dean of Research/Chair/Professor

UNITED STATES

View details

Suhui Yang

Assistant Professor

Charles R. Drew University of Medicine and Science

UNITED STATES

View details

Magda Shaheen

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

J Vadgama

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

Correction: Hao et al. Enhanced Chemoprevention of Prostate Cancer by Combining Arctigenin with Green Tea and Quercetin in Prostate-Specific Phosphatase and Tensin Homolog Knockout Mice. Biomolecules 2024, 14, 105

Inflammatory Cytokines Associated with Obesity, Type-2 Diabetes, and Hypertension Exacerbate Breast Cancer Risk in Underserved African American and Latin American Women

Overcoming Challenges in Small-Molecule Drug Bioavailability: A Review of Key Factors and Approaches

The beacon of hope program: Co-creating effective, measurable solutions for health equity

Correction: Wu et al. Expression of MALAT1 Promotes Trastuzumab Resistance in HER2 Overexpressing Breast Cancers. Cancers 2020, 12, 1918

Enhanced Chemoprevention of Prostate Cancer by Combining Arctigenin with Green Tea and Quercetin in Prostate-Specific Phosphatase and Tensin Homolog Knockout Mice

From Interaction to Intervention: How Mesenchymal Stem Cells Affect and Target Triple-Negative Breast Cancer

Advancing Cancer Research: Insights and Innovations in Pathogenesis and Targeted Therapies

Potential Therapies Targeting the Metabolic Reprogramming of Diabetes-Associated Breast Cancer

Correction: Dutta et al. Transcriptional Regulation of CCL2 by PARP1 Is a Driver for Invasiveness in Breast Cancer. Cancers 2020, 12, 1317

Squalamines in Blockade of Tumor-Associated Angiogenesis and Cancer Progression

Phytochemicals in Inhibition of Prostate Cancer: Evidence from Molecular Mechanisms Studies

Diaporine Potentiates the Anticancer Effects of Oxaliplatin and Doxorubicin on Liver Cancer Cells

Roles of Protein Disulfide Isomerase in Breast Cancer

Tumor-Derived Exosomes in Tumor-Induced Immune Suppression

Elevated Baseline Serum PD-L1 Level May Predict Poor Outcomes from Breast Cancer in African-American and Hispanic Women

Expression of MALAT1 Promotes Trastuzumab Resistance in HER2 Overexpressing Breast Cancers

Collaborators (3)

John Schloss

Suhui Yang

Magda Shaheen

Make your next move.